PRESS-RELEASE ·Filed Mar 12, 2026

XOMA

XOMA Royalty Corporation
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago WireGlobeNewswire
Press release: earnings
Actionable Insight • Neutral

Traders should monitor the upcoming earnings webcast on March 18 for potential insights into revenue, portfolio performance, or guidance. Absent material data, no immediate trading action is warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
XOMA ▲ +56.70% at T+60d
NEUTRAL call ✓ call won +56.70% · α vs SPY +46.00% · entry $26.86 → $42.09
Entry anchored
Mar 11, 03:59 PM ET
via exchange tick
T+1d
-1.79%
call -1.79% · α -1.19%
$26.38
settled 7mo ago
T+5d
+7.07%
call +7.07% · α +8.05%
$28.76
settled 7mo ago
T+20d
+36.78%
call +36.78% · α +34.81%
$36.74
settled 6mo ago
T+60d
+56.70%
call +56.70% · α +46.00%
$42.09
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

XOMA Royalty Corporation announced it will report its fourth quarter and full year 2025 financial results on March 18, 2026, followed by a webcast to discuss the results and provide a business update. The press release contains no actual financial data, only logistical details about the upcoming earnings announcement.

Key Facts

  • XOMA Royalty Corporation will report Q4 and full year 2025 financial results on March 18, 2026.
  • A webcast to discuss the results will be held the same day at 8:00 am Eastern Time.
  • No financial figures or operational updates were disclosed in this release.
  • The company is a biotech royalty aggregator with a portfolio of pre-commercial and commercial therapeutic candidates.

Financial Impact

No financial data disclosed in this release

Risk Factors

  • Lack of disclosed financials limits ability to assess performance ahead of the release.
  • Market may react negatively if actual results or guidance fall short of expectations during the webcast.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3254422
8 reports for XOMA
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +52.83%Mar 18, 2026
Filters
Rows
Reports for XOMA — sortable, filterable
TypeNow
Jul 27, 2026
9w ago
15-12G
BEARISH ★ 7/10
—awaiting T+5——
Jul 14, 2026
11w ago
8-K
BULLISH ★ 8/10
$40.17 $40.17· 0.00%▲ +0.47%$164.21 (+308.78%)
Jun 12, 2026
15w ago
DEFA14A
BULLISH ★ 8/10
$41.95 $42.00▲ +0.12%▲ +1.50%$164.21 (+291.43%)
Jun 12, 2026
15w ago
8-K
NEUTRAL ★ 4/10
$41.95 $42.00▲ +0.12%▲ +1.50%$164.21 (+291.43%)
Mar 18, 2026
28w ago
Press Release
NEUTRAL ★ 3/10
$28.76 $30.53▲ +6.15%▲ +8.37%$164.21 (+470.95%)
Mar 18, 2026
28w ago
8-K
NEUTRAL ★ 4/10
$27.35 $30.20▲ +10.42%▲ +11.14%$164.21 (+500.38%)
Mar 18, 2026
28w ago
Press Release
BULLISH ★ 8/10
$27.35 $30.20▲ +10.42%▲ +11.14%$164.21 (+500.38%)
Mar 12, 2026
29w ago
Press Release
NEUTRAL ★ 3/10
$26.86 $28.76▲ +7.07%▲ +8.05%$164.21 (+511.34%)
Showing 8 of 8

US Market Status

Market Open — Closes in 2h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Mar 12, 2026